Hydroxychloroquine-induced acute generalized exanthematous pustulosis: an adverse reaction to keep in mind during COVID-19 pandemic

J Dtsch Dermatol Ges. 2021 Jun;19(6):896-898. doi: 10.1111/ddg.14354. Epub 2021 Feb 22.

Authors

Alba Sánchez-Velázquez¹, Jorge Arroyo-Andrés¹, Daniel Falkenhain-López¹, Jose Luis Rodríguez Peralto², Pablo Luis Ortiz Romero¹, Raquel Rivera Díaz¹, Alba Calleja-Algarra¹

Affiliations

¹ Department of Dermatology, Hospital Universitario 12 de Octubre, I+12 Research Institute, Universidad Complutense, Madrid, Spain.
² Department of Pathology, Hospital Universitario 12 de Octubre, I+12 Research Institute, Universidad Complutense, Madrid, Spain.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antimalarials / adverse effects*
Antimalarials / therapeutic use
COVID-19 Drug Treatment*
Drug Eruptions / etiology*
Drug Eruptions / pathology
Female
Humans
Hydroxychloroquine / adverse effects*
Hydroxychloroquine / therapeutic use

Substances

Antimalarials
Hydroxychloroquine